4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-17-028224
CEO and Director bought 124 shares at $3.00 ($372)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MENDLEIN JOHN CEO and Director | 2017-04-24 | Purchase | +124 | $3.00 | $372 | 327,647 | D |
| Open-market purchases · 124 sh · avg $3.00 · $372 | |||||||
Loading xslF345X03/doc4.xml…